Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 2,910 shares at $569.00 ($1.7M) on 2026-04-24, disclosed to the SEC on 2026-04-24.
Scheduled sale ($1.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |
| UTHR | SELL | 2024-09-05 | $1.8M | — | Filing → |